Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA1060 AzathramycinSummary: An antibiotic that targets the ribosome. -
BA1074 GamithromycinSummary: Gamithromycin is a macrolide antibiotic whose core biological activity is inhibition of bacterial protein synthesis, targeting the 50S subunit of the bacterial ribosome. -
BA1078 SulfamonomethoxineSummary: Broad-spectrum sulfonamide antibiotic whose core biological activity is inhibition of folic acid biosynthesis in bacteria and protozoa, targeting dihydropteroate synthase (DHPS). -
BA1083 TiamulinSummary: Tiamulin (Thiamutilin) is a diterpene antibiotic widely used in pigs and poultry to control infectious diseases. -
BA1102 CefazedoneSummary: Cefazedone (Refosporen) is a first-generation cephalosporin broad-spectrum antibiotic. Its core bioactivity is inhibition of bacterial cell wall synthesis, and its target is bacterial penicillin-binding proteins (PBPs). -
BA1108 TemafloxacinSummary: A fluoroquinolone broad-spectrum antibacterial agent whose core bioactivity is inhibition of bacterial DNA replication and transcription, targeting bacterial DNA gyrase (gyrA subunit) and topoisomerase IV (Topoisomerase IV). -
BA1116 NovobiocinSummary: Novobiocin (Albamycin) is an effective orally active antibiotic. Its targets include bacterial DNA gyrase (subunit B, inhibiting ATPase activity) and heat shock protein 90 (Hsp90, C-terminal nucleotide-binding site). -
BA1199 SisomicinSummary: Sisomicin is a broad-spectrum aminoglycoside antibiotic produced by Micromonospora inyoensis. Its core bioactivity is inhibition of bacterial protein synthesis, targeting the 30S subunit of the bacterial ribosome. -
BA1217 PropranololSummary: Propranolol is a non-selective β-adrenergic receptor (β1AR/β2AR) blocker -
BA1220 GepotidacinSummary: A novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.

